Reducing HuD Levels Alleviates Alzheimer's Disease Pathology in 5xFAD Mice.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 40351099.
- Also identified by DOI 10.1111/acel.70080 and PMC identifier 12151878.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Alzheimer's disease (AD) is the most common neurodegenerative pathology in older persons. The accumulation of amyloid β (Aβ) plaques is a major contributor to AD development. The RNA-binding protein HuD/ELAVL4 has been implicated in the formation of Aβ plaques, but its role in AD is unclear. Here, we report that ablation of HuD from CAMK2A<sup>+</sup> neurons (HuDcKO) in the 5xFAD mouse model of AD results in a significant reduction of Aβ plaques and the alleviation of some AD-associated behaviors. Given the lack of effective therapies for AD, we propose that reducing HuD levels or function can contribute to diminishing Aβ plaque formation and AD-associated pathology.
Medical subject headings
- Alzheimer Disease
- ELAV-Like Protein 4